Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jun
10
2021
Trademark Protection for CBD Supplements Steptoe & Johnson PLLC
Jun
10
2021
FDA Revokes & Revises SOIs for Yogurt Products Keller and Heckman LLP
Jun
10
2021
China on the Move: An Improving Regulatory Landscape with New Challenges Ahead – Genomics and National Security Greenberg Traurig, LLP
Jun
9
2021
Video: Leaders Moving Business Forward with Peter Mason of UNICEF McDermott Will & Emery
Jun
9
2021
HHS Issues Buprenorphine Practice Guidelines as Study Confirms Access Barriers Mintz
Jun
9
2021
General Mills Flavor Labeling Settlement Denied Keller and Heckman LLP
Jun
9
2021
Montana Will Protect Off-Duty Use of Marijuana Next Year Jackson Lewis P.C.
Jun
8
2021
Mexico Amends the Health Law Regulations with Impact in the Approval of Medicines OLIVARES
Jun
8
2021
Lawsuit Takes Aim at “Natural” Claims in Dog Shampoos Keller and Heckman LLP
Jun
8
2021
New Class Action Litigation Claims That Fish Oil Is The Modern-Day Snake Oil Epstein Becker & Green, P.C.
Jun
8
2021
New Era for Insects! Keller and Heckman LLP
Jun
7
2021
L’Occitane’s 9 Million RMB Award for Trademark Infringement in China Affirmed on Appeal Schwegman, Lundberg & Woessner, P.A.
Jun
7
2021
FDA’s Unapproved Drugs Initiative Revived, with Gusto! Mintz
Jun
7
2021
ANSES Reiterates Recommendation to Restrict Use of Products Containing Nanomaterials “That Are of Little Benefit to the Population” Bergeson & Campbell, P.C.
Jun
7
2021
Class-Action Alleges Protein Content in Purely Elizabeth Products Overstated Keller and Heckman LLP
Jun
4
2021
The FTC, CIDs and the Opioid Addiction Recovery Fraud Prevention Act Hinch Newman LLP
Jun
4
2021
EUON Publishes Nanopinion on the Need for Updating Language Regarding Nanomaterials Bergeson & Campbell, P.C.
Jun
4
2021
Class Actions Continue to Target Butter & Vanilla Keller and Heckman LLP
Jun
4
2021
PFAS Paper Mill Lawsuit Adds Additional Companies CMBG3 Law
Jun
4
2021
EEOC Updates Guidance on COVID-19 Vaccination Policies, Including Mandates, Incentives, and Accommodations Epstein Becker & Green, P.C.
Jun
4
2021
FDA Ban On PFAS In Food Packaging Brought To Forefront CMBG3 Law
Jun
4
2021
Titanium Dioxide: An Unexpected Decision from EFSA Keller and Heckman LLP
Jun
3
2021
FDA Launches Food Safety Traceability Challenge Keller and Heckman LLP
Jun
3
2021
Governor Announces Acceleration of Michigan’s “Vacc to Normal” Plan Varnum LLP
Jun
3
2021
Federal and State Cannabis Rules Are Moving in Different Directions – Diagnosing Health Care [PODCAST] Epstein Becker & Green, P.C.
Jun
2
2021
How Do I Know If I Have A Singulair Lawsuit Claim Stark & Stark
Jun
2
2021
Agribusiness Remains a Target for Hackers Ward and Smith, P.A.
Jun
2
2021
Consent Decree Entered for Real Water Hepatitis Outbreak Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins